Medtronic Revenue increased by 0.6% to $9.02B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.7%, from $8.29B to $9.02B. Over 4 years (FY 2021 to FY 2025), Revenue shows an upward trend with a 2.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growth in market share or higher demand, while a decrease may signal market saturation or competitive pressure.
Represents the total consideration received from customers for the sale of goods or services, excluding any sales-relate...
Standard across all public companies; comparable to 'Net Sales' or 'Total Revenue' at peer distributors.
other_revenue_from_contract_with_customer_excluding_asse_0d5b70| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.19B | $7.99B | $7.85B | $7.76B | $8.09B | $7.37B | $7.59B | $7.73B | $8.55B | $7.70B | $7.98B | $8.09B | $8.59B | $7.92B | $8.40B | $8.29B | $8.93B | $8.58B | $8.96B | $9.02B |
| QoQ Change | — | -2.5% | -1.8% | -1.1% | +4.2% | -8.9% | +2.9% | +1.9% | +10.6% | -9.9% | +3.7% | +1.3% | +6.2% | -7.8% | +6.2% | -1.3% | +7.7% | -3.9% | +4.5% | +0.6% |
| YoY Change | — | — | — | — | -1.2% | -7.7% | -3.3% | -0.5% | +5.6% | +4.5% | +5.3% | +4.7% | +0.5% | +2.8% | +5.2% | +2.5% | +3.9% | +8.4% | +6.6% | +8.7% |